Research Information System
Irish Journal of Medical Science, vol.194, no.2, pp.563-573, 2025 (SCI-Expanded)
Aim: The study was carried out to investigate the effect of tele-nursing based motivational interviewing on diabetes self-efficacy, self-management, and metabolic control parameters in individuals with Type 2 diabetes. Method: A parallel-group randomized controlled trial. The study was completed with 70 participants (intervention: 36; control: 34). The data were collected using the Socio-demographic and Health Related Questionnaire, the Diabetes Self-Efficacy Scale, the Diabetes Self-Management Scale. The intervention group received eight sessions tele-nursing based motivational interviewing. Instruments were administered to both groups before the intervention, at the end of the last motivational interviewing session (post-test, 3rd-month), and at 6th-month follow-up. The data were analyzed using chi-square test, independent sample t-test, and one-way ANOVA. Results: In the pre-test, there was no difference between the intervention and control groups in terms of independent variables (p > 0.05). Self-efficacy and self-management scores increased in the post-test and follow-up test of the group to which telenursing-based MI was applied, and there was a difference between the groups (p < 0.05). FBG and triglyceride levels of the intervention group decreased significantly in the post-test and follow-up test (FBG = 217.46 ± 73.88, 166.13 ± 50.71, and 161.41 ± 50.50, respectively; triglyceride = 225.28 ± 148.32, 159.68 ± 68.62, and 161.09 ± 73.06, respectively) (p < 0.05). HbA1c% level decreased significantly only in the post-test. However, no significant differences were found in terms of other metabolic parameters (p > 0.05). Conclusions: This result shows the positive effectiveness of tele-nursing based MI intervention on self-efficacy, self-management, HbA1c%, FBG, triglyceride. Public health nurses should be provided with tele-nursing based MI to individuals with type 2 diabetes in primary health care institutions. Study registration. The study was registered in ClinicalTrials NCT05628259 (prospective). Trial registration number and date of registration for prospectively registered trials. The study was registered in ClinicalTrials NCT05628259 (prospective). 2023–02-01.